Tanaka, T <br/><br/>
A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group.  [electronic resource] 

 -  Endocrinologia japonica  Aug 1991 
 - 369-76 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0013-7219 
<br/><br/><label>Standard No.: </label>10.1507/endocrj1954.38.369  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>17-Hydroxycorticosteroids--urine<br/>17-Ketosteroids--urine<br/>Adrenal Glands--drug effects<br/>Analysis of Variance<br/>Child<br/>Child, Preschool<br/>Dehydroepiandrosterone--blood<br/>Delayed-Action Preparations<br/>Dose-Response Relationship, Drug<br/>Estradiol--blood<br/>Female<br/>Follicle Stimulating Hormone--urine<br/>Humans<br/>Immunoradiometric Assay<br/>Infant<br/>Insulin-Like Growth Factor I--analysis<br/>Leuprolide--pharmacology<br/>Luteinizing Hormone--urine<br/>Male<br/>Puberty, Precocious--drug therapy<br/>Testosterone--blood